In Vitro Pyrogen Detection: the New Trend


For pharmaceutical companies, patient safety has always been the priority. That’s why pyrogen detection has become a mandatory Quality Control test for release of any parenteral drug. With the Monocyte Activation Test, the only in vitro test for the detection of the full range of pyrogens (including endotoxin and non-endotoxin pyrogens), it’s now time to move away from animal-based test for pyrogen detection. The new PyroMAT™ System provides pharma companies with a robust solution to make the move to in vitro Pyrogen Test with a ready-to use kit!


Laure Robert, Global Product Manager (Merck KGaA, Darmstadt, Germany)
Anja Fritsch, Chief Scientific Officer (Confarma, France)

Webinar introduction and speakers biography


What is a pyrogen? Why to conduct a pyrogen test? How to detect pyrogens? Current status of pyrogen detection methods?

Benefits of the PyroMAT® system and how to use it


Validation of the PyroMAT® system


Real life case study using the PyroMAT® system